Search is Powered by Google
Urology / Nephrology News

Alfuzosin Treatment Of Recently Diagnosed And Newly Symptomatic Alpha-blocker Naïve Patients With Chronic Prostatitis/Chronic Pain Syndrome

Main Category: Urology / Nephrology
Also Included In: Prostate / Prostate Cancer;  Pain / Anesthetics
Article Date: 12 Jun 2008 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:5 stars

5 (1 votes)

Health Professional:not yet rated

Article Opinions: 0 posts

ORLANDO, FL (UroToday.com) - Results from the NIH Randomized Multicenter Double-Blind Placebo Controlled Trial.

Dr. Nickel presented the use of alfuzosin in the treatment of chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS). CP is extremely prevalent with 6-9% of men suffering from this. Treatment of CP is more costly in North America than treatment for type II diabetes mellitus, he said.

Traditional therapies of antibiotics are known not to work as well as previously hoped. Alpha-blockers relax smooth muscle, improve voiding symptoms, affect alpha receptors in the central nervous system and have an anti-inflammatory effect in the lower urinary tract. A treatment effect in randomized clinical trials is noted with alpha-blockers, especially in patients not previously taking alpha-blockers. Thus, their trial included 270 men randomized to alfuzosin vs. placebo and powered to detect a difference in response rates of 40-60%. Eleven clinical centers had good recruitment distribution. Baseline patient characteristics were similar in both arms. 14% of patients withdrew and adverse events occurred in only 5%.

The primary outcome was a greater that 4 point drop in the NIH-CPSI total score. There was a response of 49% in placebo arm and 49% in the alfuzosin arm! This result does not support the use of alfuzosin in the treatment of CP.

Presented by J. Curtis Nickel, MD, at the Annual Meeting of the American Urological Association (AUA) - May 17 - 22, 2008. Orange County Convention Center - Orlando, Florida, USA.

Reported by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.

To access the latest urology news releases from UroToday, go to: www.urotoday.com

Copyright © 2008 - UroToday




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

customize your homepage

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


Hormonal Therapy: Prostate image Hormonal Therapy: Prostate

Prostate cancer is the second leading cancer killer of men in the U.S. Among the treatment options for this disease are surgery, radiation therapy and hormonal therapy, which limits the effects of male hormones on growing cancer cells. Find out how hormonal therapy is being used to fight prostate...

Yeast Infections Introduction image Yeast Infections Introduction

When women experience the signs of a yeast infection, they often prefer to self-medicate rather than check with their doctor. But the symptoms are similar to those of more serious conditions and only your doctor can tell the difference. Tune is as our experts share important information all women...

View more videos...